XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2

CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Stock issuance expenses	$ 633,807	$ 97,260
Series C Convertible Preferred Stock
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment		$ 235,640
Series D Convertible Preferred Stock
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment	$ 488,270

X

- Definition

Discount of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment

+ References

No definition available.

+ Details

Name:	crdf_DiscountofIssuanceofCommonStockPreferredStockandWarrantsforClinicalTrialFundingCommitment
Namespace Prefix:	crdf_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The cash outflow for cost incurred directly with the issuance of an equity security.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585

+ Details

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=crdf_SeriesCConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=crdf_SeriesDConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: